Guidelines for avoiding risks resulting from discontinuation of nucleos(t)ide analogues in patients with chronic hepatitis B (2012)

  • Tanaka Eiji
    Department of Medicine, Shinshu University School of Medicine
  • Matsumoto Akihiro
    Department of Medicine, Shinshu University School of Medicine
  • Suzuki Yoshiyuki
    Department of Hepatology, Toranomon Hospital
  • Kobayashi Mariko
    Department of Hepatology, Toranomon Hospital
  • Tanaka Yasuhito
    Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences
  • Shinkai Noboru
    Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences
  • Hige Shuhei
    Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University
  • Yatsuhashi Hiroshi
    The Clinical Research Center, NHO Nagasaki Medical Center
  • Nagaoka Shinya
    The Clinical Research Center, NHO Nagasaki Medical Center
  • Chayama Kazuaki
    Programs for Biomedical Research, Division of Frontier Medical Science, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University
  • Tsuge Masataka
    Programs for Biomedical Research, Division of Frontier Medical Science, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University
  • Yokosuka Osamu
    Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University
  • Imazeki Fumio
    Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University
  • Nishiguchi Shuhei
    Division of Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo College of Medicine
  • Saito Masaki
    Division of Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo College of Medicine
  • Fujiwara Kei
    Gastroenterology Section, Nagoya Daini Red Cross Hospital
  • Torii Nobuyuki
    Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University
  • Hiramatsu Naoki
    Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
  • Karino Yoshiyasu
    Department of Gastroenterology, Sapporo Kosei General Hospital

Bibliographic Information

Other Title
  • 核酸アナログ薬中止に伴うリスク回避のための指針2012―厚生労働省「B型肝炎の核酸アナログ薬治療における治療中止基準の作成と治療中止を目指したインターフェロン治療の有用性に関する研究」の報告―
  • カクサン アナログヤク チュウシ ニ トモナウ リスク カイヒ ノ タメ ノ シシン 2012 : コウセイ ロウドウショウ 「 Bガタ カンエン ノ カクサン アナログヤク チリョウ ニ オケル チリョウ チュウシ キジュン ノ サクセイ ト チリョウ チュウシ オ メザシタ インターフェロン チリョウ ノ ユウヨウセイ ニ カンスル ケンキュウ 」 ノ ホウコク

Search this article

Journal

  • Kanzo

    Kanzo 53 (4), 237-242, 2012

    The Japan Society of Hepatology

Citations (5)*help

See more

References(34)*help

See more

Details 詳細情報について

Report a problem

Back to top